blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2640854

EP2640854 - PCAT1 ncRNA AND USES THEREOF [Right-click to bookmark this link]
Former [2013/39]ncRNA AND USES THEREOF
[2017/14]
StatusNo opposition filed within time limit
Status updated on  30.12.2018
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  19.01.2018
FormerGrant of patent is intended
Status updated on  13.09.2017
FormerExamination is in progress
Status updated on  06.01.2017
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): IS		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
The Regents of The University of Michigan
1600 Huron Parkway 2nd Floor
Ann Arbor, Michigan 48109 / US
[2013/39]
Inventor(s)01 / CHINNAIYAN, Arul
51300 Plymouth Valley Drive
Plymouth Michigan 48170 / US
02 / PRENSNER, John
511 E Kingsley Street, Apt. 2
Ann Arbor Michigan 48104-1191 / US
03 / IYER, Matthew
1131 Freesia Court
Ann Arbor Michigan 48105 / US
 [2013/39]
Representative(s)Algemeen Octrooi- en Merkenbureau B.V.
P.O. Box 645
5600 AP Eindhoven / NL
[2018/08]
Former [2013/39]Algemeen Octrooi- en Merkenbureau
P.O. Box 645
5600 AP Eindhoven / NL
Application number, filing date11840840.017.11.2011
[2018/08]
WO2011US61204
Priority number, dateUS20100415490P19.11.2010         Original published format: US 415490 P
[2013/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012068383
Date:24.05.2012
Language:EN
[2012/21]
Type: A2 Application without search report 
No.:EP2640854
Date:25.09.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 24.05.2012 takes the place of the publication of the European patent application.
[2013/39]
Type: B1 Patent specification 
No.:EP2640854
Date:21.02.2018
Language:EN
[2018/08]
Search report(s)International search report - published on:KR16.08.2012
(Supplementary) European search report - dispatched on:EP03.04.2014
ClassificationIPC:C12Q1/68, G01N33/574, C12N15/113
[2013/39]
CPC:
C12Q1/6886 (EP,CN,US); C12N15/11 (EP,CN,US); C12Q2600/118 (CN,US);
C12Q2600/158 (EP,CN,US); C12Q2600/16 (US); C12Q2600/178 (EP,CN,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/39]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PCAT1 NC-RNA UND VERWENDUNG DAVON[2017/14]
English:PCAT1 ncRNA AND USES THEREOF[2017/14]
French:ARNnc PCAT1 ET UTILISATIONS DE CELUI-CI[2017/14]
Former [2013/39]NC-RNA UND VERWENDUNG DAVON
Former [2013/39]ncRNA AND USES THEREOF
Former [2013/39]ARNnc ET UTILISATIONS DE CELUI-CI
Entry into regional phase11.06.2013National basic fee paid 
11.06.2013Search fee paid 
11.06.2013Designation fee(s) paid 
11.06.2013Examination fee paid 
Examination procedure11.06.2013Examination requested  [2013/39]
24.10.2014Amendment by applicant (claims and/or description)
07.12.2015Despatch of a communication from the examining division (Time limit: M06)
07.06.2016Reply to a communication from the examining division
06.10.2016Despatch of a communication from the examining division (Time limit: M02)
16.12.2016Reply to a communication from the examining division
14.09.2017Communication of intention to grant the patent
11.01.2018Fee for grant paid
11.01.2018Fee for publishing/printing paid
11.01.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18155318.1  / EP3336200
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.12.2015
Opposition(s)22.11.2018No opposition filed within time limit [2019/05]
Fees paidRenewal fee
27.11.2013Renewal fee patent year 03
26.11.2014Renewal fee patent year 04
30.11.2015Renewal fee patent year 05
28.11.2016Renewal fee patent year 06
27.11.2017Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.11.2011
AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
MK21.02.2018
NL21.02.2018
PL21.02.2018
PT21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
TR21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
IS21.06.2018
IE17.11.2018
LU17.11.2018
MT17.11.2018
[2020/33]
Former [2020/31]HU17.11.2011
AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
MK21.02.2018
NL21.02.2018
PL21.02.2018
PT21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
TR21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
IE17.11.2018
LU17.11.2018
MT17.11.2018
Former [2020/30]HU17.11.2011
AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
NL21.02.2018
PL21.02.2018
PT21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
TR21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
IE17.11.2018
LU17.11.2018
MT17.11.2018
Former [2020/27]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
NL21.02.2018
PL21.02.2018
PT21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
TR21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
IE17.11.2018
LU17.11.2018
MT17.11.2018
Former [2020/16]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
NL21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
TR21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
IE17.11.2018
LU17.11.2018
MT17.11.2018
Former [2020/08]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
NL21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
IE17.11.2018
LU17.11.2018
MT17.11.2018
Former [2019/48]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
NL21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
IE17.11.2018
LU17.11.2018
Former [2019/34]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
NL21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
LU17.11.2018
Former [2019/33]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
MC21.02.2018
NL21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
Former [2019/13]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
NL21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SI21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
Former [2018/52]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
NL21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SK21.02.2018
SM21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
Former [2018/51]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
DK21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
NL21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SK21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
Former [2018/50]AL21.02.2018
AT21.02.2018
CY21.02.2018
CZ21.02.2018
EE21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
NL21.02.2018
PL21.02.2018
RO21.02.2018
RS21.02.2018
SE21.02.2018
SK21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
Former [2018/47]AL21.02.2018
AT21.02.2018
CY21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
IT21.02.2018
LT21.02.2018
LV21.02.2018
NL21.02.2018
RS21.02.2018
SE21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
Former [2018/46]AL21.02.2018
AT21.02.2018
CY21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
NL21.02.2018
RS21.02.2018
SE21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
Former [2018/40]AT21.02.2018
CY21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
NL21.02.2018
RS21.02.2018
SE21.02.2018
BG21.05.2018
NO21.05.2018
GR22.05.2018
Former [2018/39]AT21.02.2018
CY21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
LT21.02.2018
LV21.02.2018
NL21.02.2018
RS21.02.2018
SE21.02.2018
NO21.05.2018
GR22.05.2018
Former [2018/37]CY21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
LT21.02.2018
NL21.02.2018
NO21.05.2018
GR22.05.2018
Former [2018/36]CY21.02.2018
ES21.02.2018
FI21.02.2018
HR21.02.2018
LT21.02.2018
NL21.02.2018
NO21.05.2018
Former [2018/35]CY21.02.2018
FI21.02.2018
HR21.02.2018
LT21.02.2018
NL21.02.2018
NO21.05.2018
Documents cited:Search[A]WO9845420  (DIAGNOCURE INC [CA], et al) [A] 1-15 * the whole document *;
 [A]WO0166753  (CHIRON CORP [US], et al) [A] 1-15 * table 5; sequences 2159,2167, 2168, 2171 *;
 [X]WO2004037972  (CHIRON CORP [US], et al) [X] 1-15 * claim 1; sequences 99-108, 1197-1201 *;
 [A]US2009239221  (CHINNAIYAN ARUL M [US], et al) [A] 1-15* figure 51 *;
 [A]  - KYOKO L. YAP ET AL, "Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a", MOLECULAR CELL, (20100601), vol. 38, no. 5, doi:10.1016/j.molcel.2010.03.021, ISSN 1097-2765, pages 662 - 674, XP055105800 [A] 1-15 * figure 1 *

DOI:   http://dx.doi.org/10.1016/j.molcel.2010.03.021
 [A]  - M. HUARTE ET AL, "Large non-coding RNAs: missing links in cancer?", HUMAN MOLECULAR GENETICS, (20100820), vol. 19, no. R2, doi:10.1093/hmg/ddq353, ISSN 0964-6906, pages R152 - R161, XP055105791 [A] 1-15 * table 1 *

DOI:   http://dx.doi.org/10.1093/hmg/ddq353
 [XP]  - JOHN R PRENSNER ET AL, "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression", NATURE BIOTECHNOLOGY, (20110731), vol. 29, no. 8, doi:10.1038/nbt.1914, ISSN 1087-0156, pages 742 - 749, XP055106101 [XP] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1038/nbt.1914
International search[A]US2008076674  (LITMAN THOMAS [DK], et al);
 [XP]  - PRENSNER, J. R. ET AL., "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression.", NATURE BIOTECHNOLOGY, (20110731), vol. 29, no. 8, pages 742 - 749, XP055106101

DOI:   http://dx.doi.org/10.1038/nbt.1914
 [A]  - FU, X. ET AL., "Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene", PCGEM1. DNA AND CELL BIOLOGY., (200603), vol. 25, no. 3, pages 135 - 141, XP055107442

DOI:   http://dx.doi.org/10.1089/dna.2006.25.135
 [A]  - BUSSEMAKERS, M. J. ET AL., "DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.", CANCER RESEARCH., (19991201), vol. 59, no. 23, pages 5975 - 5979, XP002923011
 [A]  - TAFT, R. J. ET AL., "Non-coding RNAs: regulators of disease.", THE JOURNAL OF PATHOLOGY., (201001), vol. 220, no. 2, pages 126 - 139, XP055107448

DOI:   http://dx.doi.org/10.1002/path.2638
ExaminationUS2005118625
by applicantUS4323546
 US4683195
 US4683202
 US4800159
 US4965188
 US5130238
 US5225326
 US5270184
 US5283174
 US5399491
 US5455166
 EP0684315
 US5480784
 US5545524
 US5710029
 US5814447
 WO9845420
 US5824518
 US5854206
 US5925517
 US5928862
 US6034218
 US6121489
 US6150097
 US6198107
 US6262245
 US6303305
 US6534274
 US6541205
 US6573043
 US2003185830
 EP1409727
 US6828429
 US2005042638
 US2006046265
 US7008765
 US7229774
    - ROWLEY, NAT REV CANCER, (2001), vol. 1, page 245
    - MITELMAN, MUTAT RES, (2000), vol. 462, page 247
    - RABBITTS, NATURE, (1994), vol. 372, page 143
    - ROWLEY, NATURE, (1973), vol. 243, page 290
    - DE KLEIN ET AL., NATURE, (1982), vol. 300, page 765
    - DEININGER ET AL., BLOOD, (2005), vol. 105, page 2640
    - HUARTE ET AL., HUM. MOL. GEN., (2010), vol. 19, no. R2, pages R152 - R161
    - KYOKO ET AL., MOLECULAR CELL, (2010), vol. 38, no. 5, pages 662 - 674
    - GUPTA ET AL., NATURE, (2010), vol. 464, no. 7291, page 1071
    - YAP ET AL., MOL CELL, (2010), vol. 38, no. 5, page 662
    - BOS, CANCER RES., (1989), vol. 49, pages 4682 - 89
    - KRANENBURG, BIOCHIMICA ET BIOPHYSICA ACTA, (2005), vol. 1756, pages 81 - 82
    - SANGER ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 74, pages 5463 - 5467
    - MAXAM ET AL., PROC. NATL. ACAD. SCI. USA, (1977), vol. 74, pages 560 - 564
    - DRMANAC ET AL., NAT. BIOTECHNOL., (1998), vol. 16, pages 54 - 58
    - KATO, INT. J. CLIN. EXP. MED, (2009), vol. 2, pages 193 - 202
    - RONAGHI ET AL., ANAL. BIOCHEM, (1996), vol. 242, pages 84 - 89
    - MARGULIES ET AL., NATURE, (2005), vol. 437, pages 376 - 380
    - RUPAREL ET AL., PROC. NATL. ACAD. SCI. USA, (2005), vol. 102, pages 5932 - 5937
    - HARRIS ET AL., SCIENCE, (2008), vol. 320, pages 106 - 109
    - LEVENE ET AL., SCIENCE, (2003), vol. 299, pages 682 - 686
    - KORLACH ET AL., PROC. NATL. ACAD. SCI. USA, (2008), vol. 105, pages 1176 - 1181
    - BRANTON ET AL., NAT. BIOTECHNOL., (2008), vol. 26, no. 10, pages 1146 - 53
    - EID ET AL., SCIENCE, (2009), vol. 323, pages 133 - 138
    - NATURE, (2001), vol. 409, pages 953 - 958
    - KUO ET AL., AM. J. HUM. GENET, (1991), vol. 49, pages 112 - 119
    - KLINGER ET AL., AM. J. HUM. GENET., (1992), vol. 51, pages 55 - 65
    - WARD ET AL., AM. J. HUM. GENET., (1993), vol. 52, pages 854 - 865
    - MULLIS ET AL., METH. ENZYMOL., (1987), vol. 155, page 335
    - MURAKAWA ET AL., DNA, (1988), vol. 7, page 287
    - WEISS, R, SCIENCE, (1991), vol. 254, page 1292
    - WALKER, G. ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 392 - 396
    - LIZARDI ET AL., BIOTECHNOL., (1988), vol. 6, page 1197
    - KWOH ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, page 1173
    - GUATELLI ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, page 1874
    - "In Vitro Nucleic Acid Amplification Techniques", PERSING, DAVID H. ET AL., Diagnostic Medical Microbiology: Principles and Applications, AMERICAN SOCIETY FOR MICROBIOLOGY, (1993), pages 51 - 87
    - SUMERDON ET AL., NUCL. MED. BIOL, (1990), vol. 17, pages 247 - 254
    - GRIFFIN ET AL., J CLIN ONE, (1991), vol. 9, pages 631 - 640
    - LAUFFER, MAGNETIC RESONANCE IN MEDICINE, (1991), vol. 22, pages 339 - 342
    - KHAW ET AL., SCIENCE, (1980), vol. 209, page 295
    - SCHEINBERG ET AL., SCIENCE, (1982), vol. 215, page 1511
    - HNATOWICH ET AL., INT. J. APPL. RADIAT. ISOT., (1982), vol. 33, page 327
    - WONG ET AL., INT. J. APPL. RADIAT. ISOT., (1978), vol. 29, page 251
    - WONG ET AL., J. NUCL. MED., (1981), vol. 23, page 229
    - MAHER ET AL., PROC NATL ACAD SCI U S A, (2009), vol. 106, no. 30, page 12353
    - TUSHER ET AL., PROC NATL ACAD SCI U S A, (2001), vol. 98, no. 9, page 5116
    - TOMLINS ET AL., SCIENCE, (2005), vol. 310, no. 5748, page 644
    - YU ET AL., CANCER CELL, vol. 17, no. 5, page 443
    - LAXMAN ET AL., CANCER RES, (2008), vol. 68, no. 3, page 645
    - LAXMAN ET AL., NEOPLASIA, (2006), vol. 8, no. 10, page 885
    - TRAPNELL ET AL., BIOINFORMATICS, (2009), vol. 25, pages 1105 - 11
    - LANGMEAD ET AL., GENOME BIOL, (2009), vol. 10, page R25
    - WHEELER ET AL., NUCLEIC ACIDS RES, (2000), vol. 28, pages 10 - 4
    - KAROLCHIK ET AL., NUCLEIC ACIDS RES, (2003), vol. 31, pages 51 - 4
    - KENT ET AL., GENOME RES, (2002), vol. 12, pages 996 - 1006
    - TRAPNELL ET AL., NAT BIOTECHNOL, vol. 28, pages 511 - 5
    - THIERRY-MIEG ET AL., GENOME BIOL, (2006), vol. 7, no. 1, pages S12 1 - 14
    - RHEAD ET AL., NUCLEIC ACIDS RES, (2010), vol. 38, pages D613 - 9
    - GARBER ET AL., BIOINFORMATICS, (2009), vol. 25, pages I54 - 62
    - YU ET AL., CANCER CELL, vol. 17, pages 443 - 54
    - PEPKE ET AL., NAT METHODS, (2009), vol. 6, pages 22 - 32
    - TUSHER ET AL., PROC NATL ACAD SCI U S A, (2001), vol. 98, pages 5116 - 21
    - CHU ET AL., GENOME BIOL, (2008), vol. 9, page R118
    - MACDONALD; GHOSH, BIOINFORMATICS, (2006), vol. 22, pages 2950 - 1
    - TOMLINS ET AL., SCIENCE, (2005), vol. 310, pages 644 - 8
    - TRAPNELL ET AL., NATBIOTECHNOL, vol. 28, no. 5, page 511
    - TRAPNELL ET AL., BIOINFORMATICS, (2009), vol. 25, no. 9, page 1105
    - BIRNEY ET AL., NATURE, (2007), vol. 447, no. 7146, page 799
    - CARNINCI ET AL., SCIENCE, (2005), vol. 309, no. 5740, page 1559
    - HE ET AL., SCIENCE, (2008), vol. 322, no. 5909, page 1855
    - YELIN ET AL., NAT BIOTECHNOL, (2003), vol. 21, no. 4, page 379
    - GUTTMAN ET AL., NAT BIOTECHNOL, vol. 28, no. 5, page 503
    - GUTTMAN ET AL., NATURE, (2009), vol. 458, no. 7235, page 223
    - DAY ET AL., GENOME BIOL, vol. 11, no. 6, page R69
    - DHANASEKARAN ET AL., NATURE, (2001), vol. 412, no. 6849, page 822
    - GUPTA ET AL., NATURE, vol. 464, no. 7291, page 1071
    - RINN ET AL., CELL, (2007), vol. 129, no. 7, page 1311
    - TOMLINS ET AL., NATURE, (2007), vol. 448, no. 7153, page 595
    - STAVENHAGEN ET AL., CELL, (1988), vol. 55, no. 2, page 247
    - BANNERT; KURTH, PROC NATL ACAD SCI USA, (2004), vol. 101, no. 2, page 14572
    - OOSUMI ET AL., NATURE, (1995), vol. 378, no. 6558, page 672
    - ROBERTSON ET AL., NAT GENET, (1996), vol. 12, no. 4, page 360
    - CORDAUX ET AL., NAT REV GENET, (2009), vol. 10, no. 10, page 691
    - BROUHA ET AL., PROC NATL ACAD SCI U S A, (2003), vol. 100, no. 9, page 5280
    - SLOTKIN; MARTIENSSEN, NAT REV GENET, (2007), vol. 8, no. 4, page 272
    - CHO ET AL., J PATHOL, (2007), vol. 211, no. 3, page 269
    - CHALITCHAGORN ET AL., ONCOGENE, (2004), vol. 23, no. 54, page 8841
    - YEGNASUBRAMANIAN ET AL., CANCER RES, (2008), vol. 68, no. 21, page 8954
    - KUNARSO ET AL., NAT GENET.
    - LIN ET AL., CELL, (2009), vol. 139, no. 6, page 1069
    - CHOW ET AL., CELL, vol. 141, no. 6, page 956
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.